BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11

• Press Releases

  Thryv Therapeutics Receives FDA IND Clearance of THRV-1268 for Clinical Programs in Heart Failure and Atrial Fibrillation and Presents Results of SGK1 Inhibition Combined with Jardiance (empagliflozin), an SGLT2 inhibitor, in a Pressure Overload Heart Failure Model at ESC Congress 2025

  September 9, 2025

   · 

  3 min read
• Press Releases

  Matica Biotechnology and Cirsium Biosciences Announce AAV Manufacturing Collaboration

  September 9, 2025

   · 

  3 min read
• Press Releases

  Sirtex Receives Expanded CE Mark Approval for SIR-Spheres® Y-90 Resin Microspheres

  September 9, 2025

   · 

  2 min read
• Press Releases

  Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-CT-1, an Autologous CAR-T Cell Therapy for Acute Myeloid Leukemia

  September 9, 2025

   · 

  3 min read
• Press Releases

  Saol Therapeutics Receives Complete Response Letter from FDA for SL1009 (DCA) for the Treatment of Pyruvate Dehydrogenase Complex Deficiency (PDCD)

  September 9, 2025

   · 

  3 min read
• Press Releases

  Remedium Bio Announces Strategic Collaboration With Lilly to Develop Gene Therapies for Obesity and Type 2 Diabetes

  September 9, 2025

   · 

  2 min read
• Press Releases

  CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study

  September 9, 2025

   · 

  7 min read
• Press Releases

  New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM

  September 9, 2025

   · 

  9 min read
• Press Releases

  Tevogen Values TVGN-489 at $9–$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell™ Allogeneic T Cell Platform

  September 9, 2025

   · 

  4 min read
• Press Releases

  Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand

  September 9, 2025

   · 

  5 min read